SOFOSBUVIR/VELPATASVIR FIXED DOSE COMBINATION FOR 12 WEEKS IN HCV INFECTED PATIENTS PREVIOUSLY TREATED WITH PLACEBO: RESULTS OF THE DEFERRED TREATMENT STUDY (GS-US-342-1446 STUDY)

T Asselah; S Shafran; S Bourgeois; C-L Lai; M Cramp; P Mathurin; B Willems; MH Nguyen; MN Davis; KC Huang; E Svarovskaia; A Osinusi; J Mcnally; D Brainard; J McHutchison; OS Shaikh; TT Tran

SOFOSBUVIR/VELPATASVIR FIXED DOSE COMBINATION FOR 12 WEEKS IN HCV INFECTED PATIENTS PREVIOUSLY TREATED WITH PLACEBO: RESULTS OF THE DEFERRED TREATMENT STUDY (GS-US-342-1446 STUDY)

T Asselah
, S Shafran
, S Bourgeois
, C-L Lai
, M Cramp
, P Mathurin
, B Willems
, MH Nguyen
, MN Davis
, KC Huang
, E Svarovskaia
, A Osinusi
, J Mcnally
, D Brainard
, J McHutchison
, OS Shaikh
, TT Tran

Peninsula Medical School

Research output: Contribution to journal › Conference proceedings published in a journal › peer-review

Original language	English
Pages (from-to)	S827-S828
Number of pages	0
Journal	Journal of Hepatology
Volume	64
Issue number	0
Publication status	Published - 2016

Cite this

Asselah, T., Shafran, S., Bourgeois, S., Lai, C.-L., Cramp, M., Mathurin, P., Willems, B., Nguyen, MH., Davis, MN., Huang, KC., Svarovskaia, E., Osinusi, A., Mcnally, J., Brainard, D., McHutchison, J., Shaikh, OS., & Tran, TT. (2016). SOFOSBUVIR/VELPATASVIR FIXED DOSE COMBINATION FOR 12 WEEKS IN HCV INFECTED PATIENTS PREVIOUSLY TREATED WITH PLACEBO: RESULTS OF THE DEFERRED TREATMENT STUDY (GS-US-342-1446 STUDY). Journal of Hepatology, 64(0), S827-S828.

@article{6baae6cc62a843469c7086fd0d7cf763,

title = "SOFOSBUVIR/VELPATASVIR FIXED DOSE COMBINATION FOR 12 WEEKS IN HCV INFECTED PATIENTS PREVIOUSLY TREATED WITH PLACEBO: RESULTS OF THE DEFERRED TREATMENT STUDY (GS-US-342-1446 STUDY)",

author = "T Asselah and S Shafran and S Bourgeois and C-L Lai and M Cramp and P Mathurin and B Willems and MH Nguyen and MN Davis and KC Huang and E Svarovskaia and A Osinusi and J Mcnally and D Brainard and J McHutchison and OS Shaikh and TT Tran",

year = "2016",

language = "English",

volume = "64",

pages = "S827--S828",

journal = "Journal of Hepatology",

issn = "0168-8278",

publisher = "Elsevier B.V.",

number = "0",

}

Asselah, T, Shafran, S, Bourgeois, S, Lai, C-L, Cramp, M, Mathurin, P, Willems, B, Nguyen, MH, Davis, MN, Huang, KC, Svarovskaia, E, Osinusi, A, Mcnally, J, Brainard, D, McHutchison, J, Shaikh, OS & Tran, TT 2016, 'SOFOSBUVIR/VELPATASVIR FIXED DOSE COMBINATION FOR 12 WEEKS IN HCV INFECTED PATIENTS PREVIOUSLY TREATED WITH PLACEBO: RESULTS OF THE DEFERRED TREATMENT STUDY (GS-US-342-1446 STUDY)', Journal of Hepatology, vol. 64, no. 0, pp. S827-S828.

SOFOSBUVIR/VELPATASVIR FIXED DOSE COMBINATION FOR 12 WEEKS IN HCV INFECTED PATIENTS PREVIOUSLY TREATED WITH PLACEBO: RESULTS OF THE DEFERRED TREATMENT STUDY (GS-US-342-1446 STUDY). / Asselah, T; Shafran, S; Bourgeois, S et al.
In: Journal of Hepatology, Vol. 64, No. 0, 2016, p. S827-S828.

Research output: Contribution to journal › Conference proceedings published in a journal › peer-review

TY - JOUR

T1 - SOFOSBUVIR/VELPATASVIR FIXED DOSE COMBINATION FOR 12 WEEKS IN HCV INFECTED PATIENTS PREVIOUSLY TREATED WITH PLACEBO: RESULTS OF THE DEFERRED TREATMENT STUDY (GS-US-342-1446 STUDY)

AU - Asselah, T

AU - Shafran, S

AU - Bourgeois, S

AU - Lai, C-L

AU - Cramp, M

AU - Mathurin, P

AU - Willems, B

AU - Nguyen, MH

AU - Davis, MN

AU - Huang, KC

AU - Svarovskaia, E

AU - Osinusi, A

AU - Mcnally, J

AU - Brainard, D

AU - McHutchison, J

AU - Shaikh, OS

AU - Tran, TT

PY - 2016

Y1 - 2016

M3 - Conference proceedings published in a journal

SN - 0168-8278

VL - 64

SP - S827-S828

JO - Journal of Hepatology

JF - Journal of Hepatology

IS - 0

ER -